• Menu
  • Home
  • Primage Project
  • Partners
  • Resources
  • Events and News
  • Contact Us

PRedictive In-silico Multiscale Analytics to support cancer personalized diaGnosis and prognosis, Empowered by imaging biomarkers

PRIMAGE is one of the largest and more ambitious European research projects in medical imaging, artificial intelligence and childhood cancer.

About the project

The project, financed by the European Commission, has 16 European partners that are participating in the consortium and has an implementation duration of 4 years. Internationally recognized researches in in-silico technologies and clinical experts in pediatric cancer are part of the staff of PRIMAGE

This project proposes an open cloud-based platform to support decision making in the clinical management of two paediatric cancers, Neuroblastoma (NB), the most frequent solid cancer of early childhood, and the Diffuse Intrinsic Pontine Glioma (DIPG) the leading cause of brain tumour-related death in children.

PRIMAGE platform implements the latest advancement of in-silico imaging biomarkers and modelling of tumour growth towards a personalised diagnosis, prognosis and therapies follow-up.

Join our mailing list

Join our mailing list to receive all project updates.

Project Coordinator
Dr. Marti-Bonmati, Head of Medical Imaging Department and Dr. Cañete, Head of the Paediatric Oncology Unit, Hospital Universitario y Politécnnico La Fe, Valencia, Spain

Project Management Team
Mario Aznar, MATICAL Innovation, Madrid, Spain
Gracia Marti, Project Manager, GIBI230, Hospital Universitario y Politécnnico La Fe, Valencia, Spain

Dissemination Management Team
Anne Blondeel, The European Society for Paediatric Oncology (SIOPE)

 

Follow us

on Twitter

on Facebook

 

❯ Sitemap

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 826494.